Protein Tyrosine Kinase Panel as a Tool for Anticancer Drug Design

Acta Naturae - Russian Federation
doi 10.32607/actanaturae.10781
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Acta Naturae Ltd

Related search

Rational Drug Design of Axl Tyrosine Kinase Type I Inhibitors as Promising Candidates Against Cancer

Frontiers in Chemistry
Chemistry
2020English

DESIGN AND SYNTHESIS OF NEW EGFR- TYROSINE KINASE INHIBITORS CONTAINING PYRAZOLO[3,4-d]PYRIMIDINE CORES AS ANTICANCER AGENTS

Bulletin of Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2012English

A Specific Inhibitor for Tyrosine Protein Kinase From Pseudomonas.

Journal of Antibiotics
Drug DiscoveryPharmacology
1986English

The Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii as Target for Structure-Based Drug Design

Parasitology
Animal ScienceZoologyParasitologyInfectious Diseases
2017English

Identification of a Phenanthrene Derivative as a Potent Anticancer Drug With Pim Kinase Inhibitory Activity

Cancer Science
Cancer ResearchMedicineOncology
2011English

Chemical Rescue of a Mutant Protein-Tyrosine Kinase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Transcription Factor-Based Drug Design in Anticancer Drug Development

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
1997English

EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design

Journal of Cancer Research Updates
2016English

CDK4 as a Phytochemical Based Anticancer Drug Target

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy